November 13, 2024 - Transcript of Earnings Call

November 12, 2024 - Schedule of Investor Conference

November 12, 2024 - Update on revival and turnaround of Jaypee Healthcare Limited

Disclosure of Related Party Transactions for half year ended September 30, 2024

November 11, 2024 - Investor Presentation

November 7, 2024 - Newspaper Publication - Financial Results

November 7, 2024 - Audio Recording of Earnings Call

November 7, 2024 - Schedule of Investor Conference

November 5, 2024 - Presentation on Earnings Update

November 5, 2024 - Press Release: Max Healthcare fortifies its position in NCR Commenced operations at Max Hospital, Dwarka and acquired Jaypee Hospital, Noida

November 5, 2024 - Outcome of Board Meeting

November 5, 2024 - Financial Results for quarter and half year ended September 30, 2024

November 5, 2024 - Grant of options under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022

October 30, 2024 - Intimation of Board Meeting

October 30, 2024 - Schedule of Earnings Call for Investors and Analysts

October 18, 2024 - Update on voluntary liquidation of ET Planners Private Limited

October 17, 2024 - Update on revival and turnaround of Jaypee Healthcare Limited

October 14, 2024 - Cessation of Senior Management Personnel

October 4, 2024 - Update on acquisition, revival and turnaround of Jaypee Healthcare Limited

October 4, 2024 - Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018

September 30, 2024 - Revision in rating by CARE Ratings Limited

October 1, 2024 - Revision in rating(s) by CARE Ratings Limited

September 27, 2024 - Transcript of 23rd Annual General Meeting

September 26, 2024 - Update on acquisition, revival and turnaround of Jaypee Healthcare Limited

September 26, 2024 - Closure of Trading Window

September 26, 2024 - Minutes of 23rd Annual General Meeting

September 26, 2024 - Completion of tenure of Mr. Kummamuri Narasimha Murthy, Independent Director

September 20, 2024 - Voting Results and Scrutinizer’s Report for 23rd Annual General Meeting

September 20, 2024 - Summary of Proceedings of 23rd Annual General Meeting

September 13, 2024 - Agreement for revival of Jaypee Healthcare Limited and appointment of SMP

September 13, 2024 - Allotment of Equity Shares under Max Healthcare Institute Limited - Employee Stock Option Scheme 2020

September 13, 2024 - Grant of options under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022

September 13, 2024 - Press Release: Max Healthcare enters into Strategic Collaboration with Lakshdeep Group for turnaround and acquisition of controlling stake in Jaypee Healthcare Limited

September 12, 2024 - Schedule of Investor Conference

September 11, 2024 - Intimation For Voluntary Liquidation Of ET Planners Private Limited, A Step Down Wholly-Owned Subsidiary Of The Company

September 6, 2024 - Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

August 29, 2024 - Newspaper Publication - Notice of 23rd Annual General Meeting and E-Voting Information

August 27, 2024 - Newspaper Publication - Notice of 23rd Annual General Meeting and E-Voting Information

August 26, 2024 - Notice of 23rd Annual General Meeting and Integrated Annual Report for the financial year 2023-24

August 26, 2024 - Business Responsibility and Sustainability Report for the financial year 2023-24

August 24, 2024 - Appointment of Dr. Pranav C. Mehta as an Additional Director in the capacity of Independent Director

August 17, 2024 - Newspaper Publication: Information regarding 23rd Annual General Meeting, Dividend and Record Date

August 14, 2024 - TDS Communication

August 14, 2024 - Investor Presentation

August 12, 2024 -Schedule of Investor Conference

August 11, 2024 - Intimation of AGM and Record Date

August 8, 2024 - Transcript of Earnings Call

August 2, 2024 - Audio Recording of Earnings Call

August 2, 2024 -Newspaper Publication - Financial Results

August 1, 2024 - Acquisition of additional equity stake in Starlit Medical Centre Private Limited

August 1, 2024 - Presentation on Earnings Update

August 1, 2024 - Press Release: Max Healthcare accelerates its growth momentum in Q1; Successfully launches 303-bed hospital in NCR & integrates 600+ beds acquired in Q4 and executes an agreement to lease for built-to-suit 250 bed hospital in Mohali

SE Intimation for transcript of Earnings Call held on August 2, 2024

August 1, 2024 - Outcome of Board Meeting

August 1, 2024 - Financial Results for quarter ended June 30, 2024

July 31, 2024 - Allotment of Equity Shares under Max Healthcare Institute Limited - Employee Stock Option Scheme 2020

July 30, 2024 - Change in Appointed Date of Scheme of Amalgamation between Alps Hospital Limited and Max Hospitals and Allied Services Limited

July 24, 2024 - Schedule of Earnings Call for Investors and Analysts

July 24, 2024 - Intimation of Board Meeting

July 16, 2024 - Disclosure under regulation 30 of the SEBI Listing Regulations 2015

Intimation for Earnings Call audio recording – August 2, 2024

Newspaper Advertisement of Financial Results for quarter ended June 30, 2024

July 8, 2024 - Certificate under regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018

SE Intimation for agreement to Lease for setting up a 250+ bedded build-to-suit hospital at Zirakpur, Punjab

SE Intimation for acquisition of additional equity stake in Starlit Medical Centre Private Limited - August 1, 2024

July 2, 2024 - Commencement of Operations of Max Super Speciality Hospital, Dwarka

ESOP Allotment - July 31, 2024

Closure of Trading window – July 1, 2024

SE Schedule of Investor Conference 5

SE Intimation for change in Appointed Date of Scheme of Amalgamation between Alps Hospital Limited and Max Hospitals and Allied Services Limited

SE Intimation for schedule of Investor Conference - June 5, 2024

SE Intimation ASCR

SE Intimation for schedule and presentation of Investor Conference - May 28, 2024

Newspaper Advertisement of Financial Results for quarter and financial year ended March 31, 2024

Statement of Deviations

Disclosure of Related Party Transactions for half year ended March 31, 2024

May 22, 2024 - Presentation on Earnings Update

Board Meeting Outcome

SE Intimation Earnings Call

Board Meeting Intimation - May 22, 2024

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - July 16, 2024

SE Intimation PB Minutes

SE Intimation for Voting Results and Scrutinizer’s Report on Postal Ballot

SE Intimation for Hon’ble National Company Law Tribunal order for voluntary liquidation of Saket City Hospitals Limited

SE Intimation on Update on acquisition of additional equity stake in Sandhya Hydro Power Projects Balargha Private Limited

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – April 19, 2024

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - April 16, 2024

Compliance under Regulation 76 of SEBI (DP) Regulations – June30, 2024

Compliance under Regulation 76 of SEBI (DP) Regulations – March 31, 2024

Compliance under Regulation 74(5) of the SEBI (DP) Regulations – June 30, 2024

Compliance Certificate under Regulation 40(9) – March 31, 2024

Compliance under Regulation 74(5) of the SEBI (DP) Regulations – March 31, 2024

SE Intimation for Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015

SE Intimation April 6 2024

SE Intimation for Postal Ballot Notice dated March 19, 2024

SE Intimation Lucknow

SE Intimation for disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – March 29, 2024

Closure of Trading window – April 1, 2024

SE Intimation for Re-appointment of Mr. Mahendra Gumanmalji Lodha and Mr. Michael Thomas Neeb as Independent Directors

Grant of options under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022

ESOP Allotment - March 18, 2024

SE Intimation for Agreement between the Company and Touch Healthcare Private Limited & Others in respect of the ongoing arbitration proceedings

SE Intimation for Issuance of Corporate Guarantee by Crosslay Remedies Limited, a wholly-owned subsidiary

SE Intimation for disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

SE Intimation for schedule of Investor Conference – March 5, 2024

SE Intimation for Acquisition of Land Parcel allotted through e-auction for setting up of 500+ bedded Hospital in Lucknow

SE Intimation for Completion of Acquisition of 100% equity stake in Alexis Multi-Speciality Hospital Private Limited

SE Intimation - Presentation for Investor Conference - February 14, 2024

SE Intimation for Update on acquisition of equity stake in Alexis Multi-Speciality Hospital Private Limited

SE Intimation for Acquisition of 100% equity stake in Alexis Multi-Speciality Hospital Private Limited

SE Intimation for disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

SE Intimation for transcript of Earnings Call held on February 1, 2024.

SE Intimation for schedule of Investor Conference – February 4, 2024

Newspaper Advertisement of Financial Results for quarter and nine months ended December 31, 2023

February 1, 2024 - Audio Recording of Earnings Call

Statement of deviation(s) or Variation(s) – December 31, 2023

January 31, 2024 - Presentation on Earnings Update

January 31, 2024 - Press Release - Max Healthcare reports yet another quarter of stellar performance

Outcome of Board Meeting held on January 31, 2024

ESOP Allotment – January 30, 2024

Earnings Call – February 1, 2024

Board Meeting Intimation – January 31, 2024

SE Intimation for Incorporation of Max Healthcare Foundation

Compliance under Regulation 76 of the SEBI (DP) Regulations – December 31, 2023

SE Intimation for transcript of Earnings Call held on May 23, 2024

Compliance under Regulation 74(5) of the SEBI (DP) Regulations – December 31, 2023

Closure of Trading window – January 1, 2024

SE Intimation for update on petition filed by the Company against Touch Healthcare Private Limited and Others – December 19, 2023

Share Purchase Agreement to Acquire 100% stake in Starlit Medical Centre Private Limited and issuance of Corporate Guarantee

SE Intimation for disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

SE Intimation for schedule of Investor Conference – November 28, 2023 & November 29, 2023

Disclosure of Related Party Transactions for the half year ended September 30, 2023

SE Intimation for transcript of Earnings Call held on November 7, 2023.

November 10, 2023 - SE Intimation for inter-se transfer within the Promoter and Promoter Group

November 7, 2023 - Investor Presentation

Newspaper Advertisement of Financial Results for quarter and half year ended September 30, 2023

November 7, 2023 - Audio Recording of Earnings Call

SE Intimation for update on petition filed by the Company against Touch Healthcare Private Limited and Others – November 6, 2023.

Statement of deviation(s) or Variation(s) – September 30, 2023

November 6, 2023 - Presentation on Earnings Update

November 6, 2023 - Press Release

Outcome of Board Meeting held on November 6, 2023

ESOP Allotment – November 6, 2023

SE Intimation for schedule of Investor Conference – October 31, 2023

Earnings Call - November 7, 2023

Board Meeting Intimation – November 6, 2023

SE Intimation for update on petition filed by the Company against Touch Healthcare Private Limited and Others – October 25, 2023

SE Intimation for update on petition filed by the Company against Touch Healthcare Private Limited and Others – October 19, 2023

SE Intimation for update on petition filed by the Company against Touch Healthcare Private Limited and Others – October 17, 2023

SE Intimation for update on petition filed by the Company against Touch Healthcare Private Limited and Others – October 16, 2023

Compliance under Regulation 76 of the SEBI (DP) Regulations – September 30, 2023

Compliance under Regulation 74(5) of the SEBI (DP) Regulations – September 30, 2023

SE Intimation Closure of Trading Window

SE Schedule of Investor Conference 3

SE Intimation Investor Conference

SE Intimation for update on petition filed by the Company against Touch Healthcare Private Limited and Others – October 4, 2023

October 4, 2023 - Transcript of Annual General Meeting

October 4, 2023 - Minutes of Annual General Meeting

Credit Rating

Closure of Trading window – October 1, 2023

SE Intimation for Amendment in Articles of Association

Voting Results and Scrutinizer’s Report – 22nd AGM

Proceeding of AGM-September 27, 2023

SE Intimation for schedule of Investor Conference – September 20, 2023

SE Intimation for change in Senior Management Personnel

ESOP Allotment – September 13, 2023

February 1, 2024 - Audio Recording of Earnings Call

SE Intimation for update on petition filed by the Company against Touch Healthcare Private Limited and Others – September 11, 2023

Newspaper Publication – Notice of 22nd Annual General Meeting and E-voting information

September 5, 2023 - Business Responsibility and Sustainability Report for the financial year 2022-23

September 4, 2023 - Notice of 22nd Annual General Meeting and Annual Report for the financial year 2022-23

SE Intimation for writ petition filed by the Company against State of Punjab and Others

SE Intimation for update on petition filed by the Company against Touch Healthcare Private Limited and Others – September 1, 2023

Newspaper Publication - Information regarding 22nd Annual General Meeting and Record Date

SE Intimation for communication to members - Deduction of tax at source on final dividend

SE Intimation of Annual General Meeting and Record Date

SE Intimation for Appointment of Ms. Amrita Gangotra as an Additional Director (Non-Executive and Independent Woman Director)

August 21, 2023 - Investor Presentation

Minutes of Postal Ballot dated July 13, 2023

Intimation of Postal Ballot result and Scrutinizer’s Report – August 16, 2023

SE Intimation for disclosure of continuing events

SE Intimation for transcript of Earnings Call held on August 8, 2023

SE Intimation for schedule of Investor Conference

Intimation for Earnings Call audio recording - August 8, 2023

Newspaper Advertisement of Financial Results for quarter ended June 30, 2023

Statements of deviation(s) and Variation(s) - June 30, 2023

August 7, 2023 - Presentation on Earnings Update

August 7, 2023 - Press Release - Max Healthcare posts strong growth in revenue and profitability

Outcome of Board Meeting held on August 7, 2023

ESOP Allotment - August 7, 2023

SE Intimation Newspaper Advertisement

Related Party Transaction

May 22, 2024 - Press Release - Max Healthcare reports highest quarterly revenue and operating EBITDA, consummates two M&A transactions adding ~750 beds to capacity

SE Disclosure Board Meeting Intimation

SE Intimation Voting Results

SE Intimation NCLT Order SCHL

Earnings Call - August 8, 2023

Board Meeting Intimation – August 7, 2023

SE Intimation for update on petition filed by the Company against Touch Healthcare Private Limited and Others – July 27, 2023

SE Intimation for update on petition filed by the Company against Touch Healthcare Private Limited and Others

Newspaper Publication - Notice of Postal Ballot, July 2023

SE Intimation for Notice of Postal Ballot

Compliance under Regulation 76 of the SEBI (DP) Regulations – June 30, 2023

Compliance under Regulation 74(5) of the SEBI (DP) Regulations – June 30, 2023

Closure of Trading Window – June 30, 2023

SE Intimation for schedule of Investor Conference

SE Intimation for meeting with various Institutional Investors in Europe

SE Intimation for meeting with various Institutional Investors in USA

SE Intimation for update on petition filed by the Company against Touch Healthcare Private Limited and Others - June 02, 2023

May 24, 2023 - Transcript of Earnings Call held on May 17, 2023

May 20, 2023 - Schedule of Investor Meet

Newspaper Advertisement of Financial Results for quarter and financial year ended March 31, 2023

Intimation for Earnings Call audio recording - May 17, 2023

SE Intimation for Appointment of Mr. Narayan K. Seshadri as an Additional Director (Non-Executive and Non-Independent)

Annual Secretarial Compliance Report - FY' 22-23

Grant of options under Max Healthcare Institute Limited - Employee Stock Option Plan 2022

ESOP Allotment - May 16, 2023

Related Party Disclosures - Reg 23(9)_March 31, 2023

Statements of deviation(s) and Variation(s) - March 31, 2023

May 16, 2023 - Presentation on Earnings Update

May 16, 2023 - Press Release - Max Healthcare reports highest ever revenue and profitability

Outcome of Board Meeting held on May 16, 2023

SE Intimation for Agreement to sell for acquisition of land and building situated in Uttar Pradesh by Crosslay Remedies Limited, wholly-owned subsidiary

Earnings Call - May 17, 2023

Board Meeting Intimation - May 16, 2023

SE Intimation for update on petition filed by the Company against Touch Healthcare Private Limited and Others

SE Intimation for Petition filed by the Company against Touch Healthcare Private Limited and Others

MHIL – Disclosure under Large Corporate Entity – FY 2023

SE intimation for Additional details w.r.t. resignation of Ms. Harmeen Mehta (DIN: 02274379) from the position of Independent Woman Director

ESOP Allotment – April 18, 2023

SE Intimation for resignation of Ms. Harmeen Mehta (Independent Director)

April 13, 2023 - Intimation for acquisition of additional equity stake in Eqova Healthcare Private Limited

Compliance under Regulation 76 of the SEBI (DP) Regulations – March 31, 2023

Compliance under Regulation 40(9) of the SEBI LODR Regulations – March 31, 2023

Compliance under Regulation 74(5) of the SEBI (DP) Regulations – March 31, 2023

Compliance under Regulation 7(3) of the SEBI LODR Regulations – March 31, 2023

Trading window Closure: March 31, 2023

ESOP Allotment - March 16, 2023

Investor Meet - February 28, 2023 to March 02, 2023

Investors’ Conference Participation- - February 21, 2023 & February 27, 2023

February 8, 2023 - Transcript of the Earnings Call held on February 3, 2023

Investors’ Conference Participation- February 07, 2023 & February 09, 2023

Intimation for contact details of Company Secretary and Compliance Officer

Newspaper Advertisement Nine Months ended Financial Results – Dec 31, 2022

Intimation for earnings call audio recording – February 03, 2023

ESOP Allotment - February 02, 2023

Appointment of Mr. Dhiraj Aroraa as Company Secretary and Compliance Officer

February 02, 2023

Q3 FY’23 - Earning updates

Statements of deviation(s) and Variation(s) - December 31, 2022

Outcome of Board Meeting held on February 02, 2023

Update on Board Meeting for fund raising – February 02, 2023

Earnings Call – February 03, 2023

Board Meeting Intimation- February 02, 2023

Compliance under Regulation 76 of the SEBI (DP) Regulations – December 31, 2022

Compliance under Regulation 74(5) of the SEBI (DP) Regulations - December 31, 2022

Allotment of ESOP – January 18, 2023

Closure of Trading Window – December 31, 2022

Intimation for ESOP Allotment- December 15, 2022

Corrigendum for Intimation filed on December 15, 2022 for Nanavati Expansion

Stock Exchange Intimation for Nanavati Expansion

Investor Meet – December 15, 2022

Intimation for Allotment of ESOP

Intimation for Submission of Application for reclassification from Promoter to Public

November 28, 2022 - Schedule of Investor Conference

Credit Rating

Related Party Disclosures - Regulation 23(9)_September 30, 2022

November 8, 2022 - Investor Presentation

Transcript of Earnings Call - Q2 and H1 FY23

Intimation for Investor Conference

Newspaper Advertisement Six Months ended Results – Sep 30, 2022

Intimation for Earning Call audio recording - Q2 FY23

Intimation for reclassification from Promoter to Public (Extracts of minutes)

November 1, 2022 - Grant of options under Max Healthcare Institute Limited - Employee Stock Option Plan 2022

November 01, 2022

Q2 FY’23- Earning updates

Statements of deviation(s) and Variation(s)- September 30, 2022

Outcome of Board Meeting held on November 01, 2022

Intimation regarding allotment of ESOP

Intimation for Earning Call - November 02, 2022

Intimation regarding Board Meeting - November 01, 2022

Compliance under Regulation 76 of the SEBI (DP) Regulations - September 30, 2022

Compliance under Regulation 74(5) of the SEBI (DP) Regulations - September 30, 2022

SE Intimation for Resignation of Company Secretary & Compliance Officer

Re-classification of Promoter to Public category

Closure of Trading Window - Sep 30, 2022

Intimation regarding Investor Meet - Sep 29, 2022

Voting results and Scrutinizer Report - 21 AGM

Proceeding of AGM-September 26, 2022

SE Intimation for resignation of Prashant Kumar

Investor Conference- Sep 19, 2022

Intimation regarding allotment of Equity Share under MHIL ESOP Scheme-2020

Intimation Regarding Investor Conference- Sep 08, 2022

Intimation Regarding Investor Conference- Sep 07, 2022

Newspaper Advertisement –Notice of 21st AGM

Max Healthcare - 21st AGM Script

September 3, 2022 - Notice of 21st Annual General Meeting and Annual Report for the financial year 2021-22

Credit Rating

SE intimation relating to distribution of business undertaking of Saket City Hospitals to Max Healthcare Institute Limited

Q1 FY’23- Earning updates

SE Intimation regarding Appointment of Mr. Anil Bhatnagar as Non Executive Non- Independent Director and revision in term of re-appointment of Mr. Abhay Soi as Chairman and Managing Director

SE Intimation for resignation of Gaurav Trehan

August 17, 2022 - Clarification by Max Healthcare Institute Limited w.r.t the media report captioned “27% Stake in Max Healthcare Put on Block Amid KKR Exit Reports

Transcript of Earnings call - Q1’FY23

Newspaper Advertisement Quarterly Financial Results - June 30, 2022

Earning call audio recording Intimation – Q1 FY23

August 10, 2022 - Grant of stock options under Max Healthcare Institute Limited ESOP-2020 Scheme

August 10, 2022 - Intimation of placing the matter before the Board of Directors w.r.t. penalty imposed by the Stock Exchanges

August 10, 2022

Outcome of Board Meeting held on August 10, 2022

Q1 FY’23- Earning updates

Notice_of_Board_Meeting- August 10, 2022

2022/07/18 Stock Exchange Intimation - Livemint Article

Compliance under Regulation 76 of the SEBI (DP) Regulations - June 30, 2022

Compliance under Regulation 74(5) of the SEBI (DP) Regulations - June 30, 2022

Closure of trading window- June 30, 2022

SE intimation relating to Voluntary Liquidation of Saket City Hospitals Limited

Related Party Disclosure- Reg-23(9)_March 31, 2022

June 3, 2022 - Intimation relating to Crosslay Remedies Limited becoming wholly owned subsidiary of Max Healthcare Institute Limited

Transcript Earnings Call- Q4 FY22

Annual Secretarial Compliance Report – FY 21-22

Newspaper Advertisement of Financial Results – March 31, 2022

May 26, 2022 - Audio Recording of Earnings Call

Q4 FY'22 - Earnings Updates

May 25, 2022

Outcome of Board Meeting held on May 25, 2022

Earnings Call - May 26, 2022

Notice of Board Meeting - May 25, 2022

Merger of Alps Hospital Limited with Max Hospitals and Allied Services Limited

Intimation of Postal Ballot result and Scrutinizer Report- May 06, 2022

MHIL - Disclosure under Large Corporate Entity FY 22

April 12, 2022 - ESOP Allotment of equity shares against exercise of stock options under “Max Healthcare Institute Limited – Employee Stock Option Plan 2020”

Compliance under Regulation 40(9)- March 31, 2022

Compliance under Regulation 76 of the SEBI (DP) Regulations - March 31, 2022

Compliance under Regulation 7(3) of the SEBI LODR Regulations- March 31, 2022

Compliance under Regulation 74(5) of the SEBI (DP) Regulations- March 31, 2022

Newspaper Publications – Postal Ballot, April 2022

April 4, 2022 - Intimation for Postal Ballot Notice

Nomination of Independent Director on the Board of Crosslay Remedies Limited

Closure of Trading window-March 31, 2022

Intimation of approval for reclassification of certain shareholders from ‘Promoter’ category to ‘Public’ category

Resignation of Ms. Ananya Tripathi and Appointment of Mr. Gaurav Trehan

Investor Meet - March 03 & 07, 2022

Investor Meet – Feb 24, 2022

Investor Conference – Feb 24, 2022

Investor Meet – Feb 16, 2022

Newspaper Advertisement Nine Months Ended Results – Dec 31, 2021

February 12, 2022 - ESOP Allotment of equity shares against exercise of stock options under “Max Healthcare Institute Limited - Employee Stock Option Plan 2020”

Q1 FY’23- Earning updates

February 12, 2022

Outcome of Board Meeting held on Feb 12, 2022

February 11, 2022

MHIL SEs Intimation Regulation 30 – Acquisition of equity stake in Eqova Healthcare Private Limited

Earning Call – Feb 15, 2022

Investor Meet – Feb 08 & 09, 2022

February 7, 2022 - Investor Presentation

Investor Meet – Feb 07, 08, 09, 10 & 11, 2022

Board Meeting intimation February 12, 2022

February 02, 2022 - Meeting of Board of Directors of the Company

January 20, 2022

MHIL SEs Intimation Regulation 30 – Long term services agreement with Muthoot Hospitals Private Limited

Compliance under Regulation 76 of the SEBI (DP) Regulations - Dec 31, 2021

MHIL SE Intimation - Financial Impact of VRS

Investor Meet - Jan 18, 2022

January 17, 2022 - Intimation of violation of the Company’s Code of Conduct under PIT Regulations

Investor Conference - Jan 12, 2022

Compliance under Regulation 74(5) of the SEBI (DP) Regulations- Dec 31, 2021

Closure of Trading Window - Dec 31, 2021

December 29, 2021 - Intimation of depositing the penalty amount received from Designated Person to SEBI – IPEF Account

Investor Meet - Canara Dec 23, 2021

Investor Meet :- Dec 23, 2021

Investor Meet - Dec 23, 2021

Voluntary liquidation of Saket City Hospitals Limited

Investor Meet - Dec 15, 2021

Investor Meet - Dec 09, 2021

Re-classification of certain Promoters to Public category- Stock Exchange Application Intimation

Investor Meet - Dec 07, 2021

Re-classification of certain Promoters to PUBLIC from PROMOTERS

December 1, 2021 - ESOP Allotment of equity shares against exercise of stock options under “Max Healthcare Institute Limited - Employee Stock Option Plan 2020”

Intimation under Regulation 30, withdrawal of Merger between ALPS & SCHL

Investor Meet - Nov 30, 2021

Investor meet - Nov 25, 2021

Investor Meet - Nov 23, 24, 25 & 26 2021

Investor Meet - Nov 17, 2021

Investor Meet- Nov 16 & 18, 2021

Q1 FY’23- Earning updates

Investor Meet - Nov 15, 2021

Newspaper Advertisement Six Months Ended Results – Sep 30 2021

Participation in Investor Conference Call – Nov 15, 2021

November 12, 2021 - ESOP Allotment of equity shares against exercise of stock options under “Max Healthcare Institute Limited - Employee Stock Option Plan 2020”

ESOP Grant 2021

Outcome of Board Meeting held on November 12, 2021

Scrutinizer’s Report and Postal Ballot voting result Nov 2021

Earning Call - Nov 15, 2021

Board Meeting Intimation - November 12, 2021

October 26, 2021 - ESOP Allotment of equity shares against exercise of stock options under “Max Healthcare Institute Limited - Employee Stock Option Plan 2020”

October 12, 2021 - Intimation for Postal Ballot Notice

Board Approval - Amendment in AOA & Conducting Postal Ballot

SAST - Annexure II - Pledge by Kayak

Compliance under 76 of the SEBI (DP) Regulations - Sept 30, 2021

Compliance under 74(5) of the SEBI (DP) Regulations - Sept 30, 2021

October 4, 2021

Updates - 1000 beds addition in Gurugram

Voting Result & Scrutnizer's Report- 20th AGM

Closure of Trading Window - Sept 30, 2021

Proceeding of AGM-September 29, 2021

MHIL intimation for amendment to the SHA Dec 24, 2018

SE Intimation – Presentation for Investor Conference

Investor Meet - Sep 22, 2021

Investor Meet - Sep 21, 2021

Investor Meet - Sep 20, 2021

Investor Meet - Sep 17, 2021

Newspaper Advertisement - Notice of 20th AGM

September 3, 2021 - Notice of 20th Annual General Meeting and Annual Report for the financial year 2020-21

Newspaper Advertisement – Intimation of 20th AGM/ Email Registration

MHIL Intimation for Change in Date of 20th AGM

MHIL SEs Intimation of VRS in Nanavati

Investor Meet - Sep 06, 2021

August 27, 2021

Intimation to Stock Exchange - Acquisition of ET Planners Pvt Ltd through ALPS Hospital Ltd

August 27, 2021 - Press Release - Acquisition of equity stake in Eqova Healthcare Private Limited

August 27, 2021 - SE Intimation for acquisition of equity stake in Eqova Healthcare Private Limited

Intimation to Stock Exchanges_additional investment in Alps Hospitals Limited (WoS)

Investor Call Intimation August - 24, 25, 26 & 27, 2021

Completion of Open Market Sale by Promoters for achieving MPS

Intimation to Stock Exchange – Open Market Sale

SEBI Approval Letter – Open Market Sale/MPS Threshold

Newspaper Advertisement- Quarterly Financial Results- June 30, 2021

Investor Call Intimation - August 11 & 12, 2021

Outcome of Board Meeting held on August 10, 2021

Earning Call Intimation - Investors

Announcement under Regulation 30 of SEBI (LODR) corporate guarantee

Board Meeting Intimation - August 10, 2021

July 8, 2021 - Compliance under Regulation 74(5) of the SEBI (DP) Regulations - June 30, 2021

July 7, 2021 - Intimation of violation of the Company’s Code of Conduct under PIT Regulations

Revision in Credit Rating Intimation

July 1, 2021 - Intimation of depositing the penalty amount received from Designated Person to SEBI – IPEF Account

Closure of Trading Window - June 30, 2021

Investor Meet - June, 30 2021

Related Party Disclosure - Reg 23(9) _March 31, 2021

Annual Secretarial Compliance Report - FY 20-21

Disclosure under Regulation 4(1) of PIT Regulations 2015

Investor Meet - June, 15, 16 & 17 2021

Investor Conference Calls June 14 & 15, 2021

Investor Meet - June, 07 2021

Investor Meet - June, 02 2021

Investor Presentation - June, 01 2021

Investor Meet - May, 30 2021

Newspaper Advertisement of Financial Results - March 31, 2021

May 28, 2021 - Corrigendum to the outcome of the Board Meeting held today i.e. May 28, 2021

Outcome of Board Meeting held on May 28, 2021

Appointment of Ms. Harmeen Mehta, as Non- Executive Independent Director

May 21, 2021 - Resiqnation of Mr. Upendra Kumar Sinha as an Independent Director

Earning Call - May 31st, 2021

Board Meeting Intimation - May 28, 2021

April 22, 2021 - Initial Disclosure

Compliance under regulation 40(9)- March 31, 2021

Compliance under Regulation 7(3) - March 31, 2021 BSE

Compliance under Regulation 74(5) of the SEBI (DP) Regulations- March 31, 2021

April 13, 2021 - Intimation of depositing the penalty amount received from Designated Person to SEBI – IPEF Account

SE intimation on Intimation of placing of matter before the Board of Directors

SE intimation on Intimation of proposed formation of a wholly owned subsidiary

SE intimation on Acquisition of Stake in Crosslay Remedies Limited

Closure of Trading Window - March 31, 2021

Investor Meet - Mar, 30 2021

March 26, 2021 - Intimation for approval of the Scheme of Amalgamation of ALPS and SCHL

Investor Meet - Mar, 23 2021

SE intimation on Acquisition of Stake in Saket City Hospitals Ltd

March 11, 2021 - Intimation of participation by the Company in the Investor Conference

March 10, 2021

SE Intimation Relating to List of Allottees

SE intimation relating to Allotment of equity shares of face value of INR 10 each (“Equity Shares”)

SE intimation relating to approval and adoption of the placement document dated March 9, 2021

SE Intimation March 09 2021

Regulation 30 & 29 Announcement Outcome of QIP

Regulation 30 Performa Financial Information & Special Purpose Consolidated Financial Information

Earnings Conference Call Transcript February 08, 2021

Intimation of schedule of Investor/

Investor Meet - Feb, 16 2021

February 13, 2021 - Intimation of violation of the Company’s Code of Conduct under PIT Regulations

Investor Meet - Feb, 12 2021

Investor Meet - Feb, 11 2021

Investor Meet - Feb, 10 2021

February 9, 2021 - Updated Presentation for the Investors

Investors Meet Intimation Feb 08 2021

February 7, 2021 - Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

Newspaper Advertisement- Quarterly Financial Results- December 31, 2020

February 7, 2021 - Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

Q3 FY' 21 – Press Release

Board Meeting Outcome & Investor Call held on February 06, 2021

Q3 FY' 21 – Earning Updates

Investor Meet- 29.01.2021

Board Meeting intimation- 27.01.2021

January 27, 2021 - Meeting of the Board of Directors of the Company on February 06, 2021

Reconciliation of Share Capital Audit Report– December 31, 2020

Certificate under regulation 74(5) of DP Regulations–December 31, 2020

Closure of trading Window- December 31, 2020

Announcement Under Regulation 30 (LODR)-Code Of Conduct Under SEBI (PIT) Regulations, 30.12.2020

Investor Meet 30.12.2020

Investor Meet 29.12.2020

Investor Meet 25.12.2020

Investor Meet 21.12.2020

Investor Meet 17.12.2020

Compliance under Reg 23(9)- December 09, 2020

Investor Meet - 4.12.2020

Investor Meet - 3.12.2020

Investor Meet - 2.12.2020

Investor Meet - 26.11.2020

Investor Meet - 23.11.2020

November 13, 2020 - Newspaper Advertisement - Quarterly Financial Results - September 30, 2020

Q2 FY'21 - Earning Updates

Outcome of Board Meeting held on November 11, 2020

Earning Call- 13.11.2020

Notice Board Meeting-31-10-2020

Credit Rating

Board Meeting intimation- 30-10-2020

Reconciliation of Share Capital Audit Report– Sept 20, 2020

Certificate under regulation 74(5) of DP Regulations– September 2020- 20.10.2020

Compliance Under Regulation 40(9)– September 2020-19.10.2020

Certificate under regulation 7(3)– September 2020- 19.10.2020

October 19, 2020 - Intimation of violation of the Company’s Code of Conduct under PIT Regulations

Investor Meet– October 08 & 09, 2020

Voting result & Scrutinizer’s Report- AGM

Intimation of Completion of Open market sale of Equity shares

Closure of trading Window- September 30, 2020

Proceeding of AGM-September 29, 2020

Grant of ESOP

Investor Meet– September 28, 29 & 30, 2020

Investor Meet– September 25, 2020

Investor Presentation- September 24, 2020

Intimation for open market sale of equity shares

MHIL SEs Intimation Regulation 30 – Acquisition of additional equity stake in Eqova Healthcare Private Limited - April 13, 2023

September 13, 2020 - Intimation of Schedule of Investors’ meet

Newspaper Advertisement for Notice of 19th AGM

Investor Meet– September 08 & 09, 2020

Intimation regarding AGM timings

Intimation to Stx - Annual Report

Stx Intimation- Notice of AGM

Intimation of Amendments to the Articles of Association

September 2, 2020 - SE Intimation for disclosure of contact details of Key Managerial Personnel under Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Newspaper Advertisement for Email Registration

Q1 FY'21 - Earnings Updates

September 01, 2020

Outcome of Board Meeting held on September 1, 2020

Investor Conference – September 3, 2020

Earning Call-September 02, 2020

Transcript for Investor and Analysts Conference Call, July 30, 2020

August 26, 2020 - Closure of Trading Window

Notice of Board Meeting - September 01, 2020

August 24, 2020 - Disclosure under Regulation 10(6) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

August 21, 2020

Investor Presentation July 27, 2020

Intimation Regarding Investor Conference- Sep 19, 2022

SE intimation regarding revision in Credit Ratings of Max Healthcare Institute Limited and its Material Subsidiaries

SE intimation relating to Crosslay Remedies Limited becoming Wholly Owned Subsidiary of Max Healthcare Institute Limited

Compliance under 76 of the SEBI (DP) Regulations - June 30, 2021

Compliance under 74(5) of the SEBI (DP) Regulations - June 30, 2021

Compliance under Regulation 76 of the SEBI (DP) Regulations- March 31, 2021

Board Meeting Intimation - February 06, 2021

Announcement Under Regulation 30 (LODR)-Code Of Conduct Under SEBI (PIT) Regulations, 2015

Board Meeting Intimation – August 26, 2020

Credit Rating Intimation

Transcript for Investor and Analysts Conference Call, July 30, 2020

Announcements & Disclosures

Corporate Announcements

Shareholding Pattern

Quarterly Corporate Governance Report